Voiding impairment after prostate biopsy: Does tamsulosin treatment before biopsy decrease this morbidity?

Urology

Volumn 62, Issue 6, 2003, Pages 1050-1053

  Bozlu, Murat ^a   Ulusoy, Ercüment ^b   Doruk, Erdal ^b   Çayan, Selahittin ^b   Canpolat, Bülent ^b   Schellhammer, Paul F ^b   Akbay, Erdem ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; TAMSULOSIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FLOW RATE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; URINE RETENTION;

EID: 0345528215     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.07.006     Document Type: Article

References (10)

1. Galetti T.P., Dal Moro F., Milani C., et al. Patient's preparation in order to reduce pain, anxiety and complications of TRUS prostatic biopsies. Eur Urol. 1:(suppl 6):2002;3-7.
2. Raajmakers R., Kirkels W.J., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within population-based screening program. Urology. 60:2002;826-830.
3. Zisman A., Leibovici D., Kleinmann J., et al. The impact of prostate biopsy on patient well-being a prospective study of voiding impairment . J Urol. 166:2001;2242-2246.
4. Makinen T., Auvinen A., Hakama M., et al. Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice a prospective, controlled study . Urology. 60:2002;846-850.
5. Borboroglu P.G., Comer S.W., Riffenburgh R.H., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 163:2000;158-162.
6. Soloway M.S., Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 163:2000;172-173.
7. Bozlu M., Doruk E., Akbay E., et al. Effect of administration mode (patient vs physician) and patient's educational level on the Turkish version of the International Prostate Symptom Score. Int J Urol. 9:2002;417-421.
8. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1557.
9. Schulman C.C., Lock T.M.T.W., Buzelin J.M., et al. Long term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. J Urol. 166:2001;1358-1363.
10. O'Leary M.P. Tamsulosin current clinical experience . Urology. 58:(suppl 6A):2001;42-48.